Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Return on Assets (2019 - 2025)

Eton Pharmaceuticals (ETON) has disclosed Return on Assets for 7 consecutive years, with 0.05% as the latest value for Q4 2025.

  • Quarterly Return on Assets rose 2.0% to 0.05% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.05% through Dec 2025, up 2.0% year-over-year, with the annual reading at 0.05% for FY2025, 2.0% up from the prior year.
  • Return on Assets hit 0.05% in Q4 2025 for Eton Pharmaceuticals, up from 0.06% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.07% in Q3 2023 to a low of 0.52% in Q2 2022.
  • Historically, Return on Assets has averaged 0.2% across 5 years, with a median of 0.12% in 2021.
  • Biggest five-year swings in Return on Assets: surged 141bps in 2021 and later plummeted -32bps in 2022.
  • Year by year, Return on Assets stood at 0.07% in 2021, then crashed by -436bps to 0.39% in 2022, then soared by 92bps to 0.03% in 2023, then crashed by -131bps to 0.07% in 2024, then soared by 31bps to 0.05% in 2025.
  • Business Quant data shows Return on Assets for ETON at 0.05% in Q4 2025, 0.06% in Q3 2025, and 0.04% in Q2 2025.